secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0000950170-24-092432
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia appoints CEO Thomas Schaefer to board as Class I director, filling Jacot vacancy
--------------------------------------------------------------------------------

- Thomas J. Schaefer, current president and CEO, appointed Class I director effective August 1, 2024.
- Appointment fills board vacancy created by Stanley Jacot's resignation on July 2, 2024.
- Schaefer has served as CEO since July 2022 and as CFO since January 2023; no compensation change disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017024092432/0000950170-24-092432-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017024092432/rkda-20240801.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-092432

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer